119 related articles for article (PubMed ID: 36654075)
21. Expression Profiling of Clinical Specimens Supports the Existence of Neural Progenitor-Like Stem Cells in Basal Breast Cancers.
Panaccione A; Guo Y; Yarbrough WG; Ivanov SV
Clin Breast Cancer; 2017 Jul; 17(4):298-306.e7. PubMed ID: 28216417
[TBL] [Abstract][Full Text] [Related]
22. Embryonic stem cell factors and pancreatic cancer.
Herreros-Villanueva M; Bujanda L; Billadeau DD; Zhang JS
World J Gastroenterol; 2014 Mar; 20(9):2247-54. PubMed ID: 24605024
[TBL] [Abstract][Full Text] [Related]
23. Silencing PRDM14 expression by an innovative RNAi therapy inhibits stemness, tumorigenicity, and metastasis of breast cancer.
Taniguchi H; Hoshino D; Moriya C; Zembutsu H; Nishiyama N; Yamamoto H; Kataoka K; Imai K
Oncotarget; 2017 Jul; 8(29):46856-46874. PubMed ID: 28423353
[TBL] [Abstract][Full Text] [Related]
24. Identification of Biomarkers Associated with Hepatocellular Carcinoma Stem Cell Characteristics Based on Co-Expression Network Analysis of Transcriptome Data and Stemness Index.
Zhao Z; Mu H; Feng S; Liu Y; Zou J; Zhu Y
Crit Rev Eukaryot Gene Expr; 2022; 32(2):47-60. PubMed ID: 35381131
[TBL] [Abstract][Full Text] [Related]
25. IL20RA signaling enhances stemness and promotes the formation of an immunosuppressive microenvironment in breast cancer.
Gao W; Wen H; Liang L; Dong X; Du R; Zhou W; Zhang X; Zhang C; Xiang R; Li N
Theranostics; 2021; 11(6):2564-2580. PubMed ID: 33456560
[No Abstract] [Full Text] [Related]
26. Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy.
Pham PV; Phan NL; Nguyen NT; Truong NH; Duong TT; Le DV; Truong KD; Phan NK
J Transl Med; 2011 Dec; 9():209. PubMed ID: 22152097
[TBL] [Abstract][Full Text] [Related]
27. Mining Transcriptomic Data to Uncover the Association between CBX Family Members and Cancer Stemness.
Czerwinska P; Mackiewicz AA
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361869
[TBL] [Abstract][Full Text] [Related]
28. miR-145-5p as a predictive biomarker for breast cancer stemness by computational clinical investigation.
Rajarajan D; Kaur B; Penta D; Natesh J; Meeran SM
Comput Biol Med; 2021 Aug; 135():104601. PubMed ID: 34186326
[TBL] [Abstract][Full Text] [Related]
29. Stemness, cancer and cancer stem cells.
Wong DJ; Segal E; Chang HY
Cell Cycle; 2008 Dec; 7(23):3622-4. PubMed ID: 19029796
[TBL] [Abstract][Full Text] [Related]
30. Microenvironment dependent gene expression signatures in reprogrammed human colon normal and cancer cell lines.
Strainiene E; Binkis M; Urnikyte S; Stankevicius V; Sasnauskiene A; Kundrotas G; Kazlauskas A; Suziedelis K
BMC Cancer; 2018 Feb; 18(1):222. PubMed ID: 29482503
[TBL] [Abstract][Full Text] [Related]
31. A c-Myc-regulated stem cell-like signature in high-risk neuroblastoma: A systematic discovery (Target neuroblastoma ESC-like signature).
Yang XH; Tang F; Shin J; Cunningham JM
Sci Rep; 2017 Mar; 7(1):41. PubMed ID: 28246384
[TBL] [Abstract][Full Text] [Related]
32. Cleaved CD44 intracellular domain supports activation of stemness factors and promotes tumorigenesis of breast cancer.
Cho Y; Lee HW; Kang HG; Kim HY; Kim SJ; Chun KH
Oncotarget; 2015 Apr; 6(11):8709-21. PubMed ID: 25909162
[TBL] [Abstract][Full Text] [Related]
33. p97/VCP is highly expressed in the stem-like cells of breast cancer and controls cancer stemness partly through the unfolded protein response.
Li C; Huang Y; Fan Q; Quan H; Dong Y; Nie M; Wang J; Xie F; Ji J; Zhou L; Zheng Z; Wang L
Cell Death Dis; 2021 Mar; 12(4):286. PubMed ID: 33731668
[TBL] [Abstract][Full Text] [Related]
34. TMPRSS4 promotes cancer stem-like properties in prostate cancer cells through upregulation of SOX2 by SLUG and TWIST1.
Lee Y; Yoon J; Ko D; Yu M; Lee S; Kim S
J Exp Clin Cancer Res; 2021 Nov; 40(1):372. PubMed ID: 34809669
[TBL] [Abstract][Full Text] [Related]
35. Transcriptional factor six2 promotes the competitive endogenous RNA network between CYP4Z1 and pseudogene CYP4Z2P responsible for maintaining the stemness of breast cancer cells.
Zheng L; Guo Q; Xiang C; Liu S; Jiang Y; Gao L; Ni H; Wang T; Zhao Q; Liu H; Xing Y; Wang Y; Li X; Xi T
J Hematol Oncol; 2019 Mar; 12(1):23. PubMed ID: 30832689
[TBL] [Abstract][Full Text] [Related]
36. Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells.
Alberti L; Losi L; Leyvraz S; Benhattar J
PLoS One; 2015; 10(7):e0132977. PubMed ID: 26185996
[TBL] [Abstract][Full Text] [Related]
37. Human hepatic cancer stem cells are characterized by common stemness traits and diverse oncogenic pathways.
Marquardt JU; Raggi C; Andersen JB; Seo D; Avital I; Geller D; Lee YH; Kitade M; Holczbauer A; Gillen MC; Conner EA; Factor VM; Thorgeirsson SS
Hepatology; 2011 Sep; 54(3):1031-42. PubMed ID: 21618577
[TBL] [Abstract][Full Text] [Related]
38. Identification of key genes controlling breast cancer stem cell characteristics via stemness indices analysis.
Pei J; Wang Y; Li Y
J Transl Med; 2020 Feb; 18(1):74. PubMed ID: 32050983
[TBL] [Abstract][Full Text] [Related]
39. Human endogenous retroviruses role in cancer cell stemness.
Matteucci C; Balestrieri E; Argaw-Denboba A; Sinibaldi-Vallebona P
Semin Cancer Biol; 2018 Dec; 53():17-30. PubMed ID: 30317035
[TBL] [Abstract][Full Text] [Related]
40. Reprogramming of non-genomic estrogen signaling by the stemness factor SOX2 enhances the tumor-initiating capacity of breast cancer cells.
Vazquez-Martin A; Cufí S; López-Bonet E; Corominas-Faja B; Cuyàs E; Vellon L; Iglesias JM; Leis O; Martín AG; Menendez JA
Cell Cycle; 2013 Nov; 12(22):3471-7. PubMed ID: 24107627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
